标题
Current therapies and new developments in NASH
作者
关键词
-
出版物
GUT
Volume -, Issue -, Pages gutjnl-2021-326874
出版商
BMJ
发表日期
2022-06-17
DOI
10.1136/gutjnl-2021-326874
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial
- (2021) Anat Yaskolka Meir et al. GUT
- Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies
- (2021) Alessandro Mantovani et al. GUT
- From the origin of NASH to the future of metabolic fatty liver disease
- (2021) Andreas Geier et al. GUT
- A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH
- (2021) Amaro Taylor‐Weiner et al. HEPATOLOGY
- The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
- (2021) Lulu Sun et al. Nature Reviews Gastroenterology & Hepatology
- Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity
- (2021) Vinod K. Rustgi et al. GASTROENTEROLOGY
- Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
- (2021) Ferenc Emil Mózes et al. GUT
- Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
- (2021) Roser Pinyol et al. JOURNAL OF HEPATOLOGY
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
- (2021) Giovanni Targher et al. Lancet Gastroenterology & Hepatology
- Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease
- (2021) N. Tamaki et al. Clinical Gastroenterology and Hepatology
- Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
- (2021) Fasiha Kanwal et al. GASTROENTEROLOGY
- Ultra‐processed food is associated with features of metabolic syndrome and non‐alcoholic fatty liver disease
- (2021) Dana Ivancovsky‐Wajcman et al. LIVER INTERNATIONAL
- Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
- (2021) Stephen A. Harrison et al. NATURE MEDICINE
- Dietary carbohydrates and fats in nonalcoholic fatty liver disease
- (2021) Hannele Yki-Järvinen et al. Nature Reviews Gastroenterology & Hepatology
- Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities
- (2021) Richard Radun et al. SEMINARS IN LIVER DISEASE
- Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease
- (2021) Anne-Marieke Van Dijk et al. Journal of Clinical Medicine
- FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis
- (2021) Yasaman Vali et al. Journal of Clinical Medicine
- “Sweet death”: Fructose as a metabolic toxin that targets the gut-liver axis
- (2021) Mark A. Febbraio et al. Cell Metabolism
- The fecal mycobiome in non-alcoholic fatty liver disease
- (2021) Münevver Demir et al. JOURNAL OF HEPATOLOGY
- Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
- (2021) V. Ratziu et al. NATURE MEDICINE
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
- (2021) Sven M. Francque et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors
- (2021) Sophie C. Cazanave et al. Science Translational Medicine
- Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
- (2021) Anne Linde Mak et al. Biomedicines
- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- Serial transient elastography examinations to monitor patients with type 2 diabetes: A prospective cohort study
- (2020) Hye Won Lee et al. HEPATOLOGY
- Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease
- (2020) Donghee Kim et al. HEPATOLOGY
- Physical Activity Compared to Adiposity and Risk of Liver-Related Mortality: Results from Two Prospective, Nationwide Cohorts
- (2020) Tracey G. Simon et al. JOURNAL OF HEPATOLOGY
- Update on NAFLD genetics: from new variants to the clinic
- (2020) Eric Trépo et al. JOURNAL OF HEPATOLOGY
- FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
- (2020) Philip N Newsome et al. Lancet Gastroenterology & Hepatology
- Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis
- (2020) Yasaman Vali et al. JOURNAL OF HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis
- (2020) Shou-Sheng Liu et al. Lipids in Health and Disease
- Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
- (2020) Tracey G. Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2020) Qing Ye et al. Lancet Gastroenterology & Hepatology
- Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States
- (2020) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
- (2020) Guillaume Lassailly et al. GASTROENTEROLOGY
- Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
- (2020) Stephen A. Harrison et al. GASTROENTEROLOGY
- Driving NASH forward using the FAST score but obey the traffic lights
- (2020) Nabil Noureddin et al. HEPATOLOGY
- Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
- (2020) Beth A. Davison et al. JOURNAL OF HEPATOLOGY
- A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
- (2020) Stephen A Harrison et al. Lancet Gastroenterology & Hepatology
- Change in MRI-PDFF and Histologic Response in Patients with Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis
- (2020) Jonathan G. Stine et al. Clinical Gastroenterology and Hepatology
- Ultra-processed food consumption and type 2 diabetes incidence: A prospective cohort study
- (2020) Renata B. Levy et al. CLINICAL NUTRITION
- MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis
- (2020) Jinho Jung et al. GUT
- Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
- (2020) Olivier Govaere et al. Science Translational Medicine
- Associations Between Intake of Sugar‐Containing Beverages in Infancy With Liver Fat Accumulation at School Age
- (2020) Madelon L. Geurtsen et al. HEPATOLOGY
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease
- (2020) Vincent Wai-Sun Wong et al. Clinical Gastroenterology and Hepatology
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
- (2019) Ankur Srivastava et al. JOURNAL OF HEPATOLOGY
- Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis
- (2019) Jie Li et al. Lancet Gastroenterology & Hepatology
- Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
- (2019) Tracey G. Simon et al. ANNALS OF INTERNAL MEDICINE
- The Risk of Incident Extrahepatic Cancers is higher in Nonalcoholic Fatty Liver Disease than Obesity - a Longitudinal Cohort Study
- (2019) Alina M. Allen et al. JOURNAL OF HEPATOLOGY
- Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States
- (2019) Ilya Golovaty et al. JOURNAL OF NUTRITION
- Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists
- (2019) Rohit A. Sinha et al. THYROID
- Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2019) Stephen A Harrison et al. LANCET
- High-Throughput, Machine Learning-based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients with Nonalcoholic Fatty Liver Disease
- (2019) Roberta Forlano et al. Clinical Gastroenterology and Hepatology
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Vibration-controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Mohammad S. Siddiqui et al. Clinical Gastroenterology and Hepatology
- Non-alcoholic Steatohepatitis is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
- (2018) Zobair Younossi et al. Clinical Gastroenterology and Hepatology
- Magnetic Resonance vs Transient Elastography Analysis of Patients With Non-alcoholic Fatty Liver Disease: a Systematic Review and Pooled Analysis of Individual Participants
- (2018) Cynthia Hsu et al. Clinical Gastroenterology and Hepatology
- Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars
- (2018) Panu K. Luukkonen et al. DIABETES CARE
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease
- (2018) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- ADAPT: An algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis
- (2018) Samuel J. Daniels et al. HEPATOLOGY
- Pharmacotherapy for NASH: Current and emerging
- (2018) Monica A. Konerman et al. JOURNAL OF HEPATOLOGY
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD
- (2018) Elliot B. Tapper et al. Nature Reviews Gastroenterology & Hepatology
- Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses
- (2018) Jaehee Ahn et al. CLINICAL NUTRITION
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- Guidelines on the management of abnormal liver blood tests
- (2017) Philip N Newsome et al. GUT
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment
- (2017) Vincent Wai-Sun Wong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
- (2016) Stuart McPherson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
- (2016) Fabio Piscaglia et al. HEPATOLOGY
- Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
- (2016) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease
- (2016) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice
- (2016) Parambir S. Dulai et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Human gut microbes impact host serum metabolome and insulin sensitivity
- (2016) Helle Krogh Pedersen et al. NATURE
- NAFLD and diabetes mellitus
- (2016) Herbert Tilg et al. Nature Reviews Gastroenterology & Hepatology
- Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis
- (2016) Janki Patel et al. Therapeutic Advances in Gastroenterology
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
- (2015) Raymond Kwok et al. GUT
- Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy
- (2015) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
- (2014) Rohit Loomba et al. HEPATOLOGY
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
- (2013) Siddharth Singh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
- (2013) Jonathan E. Campbell et al. Cell Metabolism
- Liver Stiffness Is Associated With Risk of Decompensation, Liver Cancer, and Death in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis
- (2013) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification
- (2013) J K Dyson et al. JOURNAL OF CLINICAL PATHOLOGY
- Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus
- (2013) Stefan Kiechl et al. NATURE MEDICINE
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
- (2012) Pierre Bedossa et al. HEPATOLOGY
- Endpoints and clinical trial design for nonalcoholic steatohepatitis
- (2011) Arun J. Sanyal et al. HEPATOLOGY
- Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice
- (2011) Yehuda Kamari et al. JOURNAL OF HEPATOLOGY
- Unknown
- (2011) Alexander Moschen et al. MOLECULAR MEDICINE
- PPARs: diverse regulators in energy metabolism and metabolic diseases
- (2010) Yong-Xu Wang CELL RESEARCH
- Population-based risk factors and resource utilization for HCC: US perspective
- (2010) A. Sanyal et al. CURRENT MEDICAL RESEARCH AND OPINION
- Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
- (2010) S. McPherson et al. GUT
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Amy G. Shah et al. Clinical Gastroenterology and Hepatology
- Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
- (2009) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
- (2008) S A Harrison et al. GUT
- Comparison of blood tests for liver fibrosis specific or not to NAFLD
- (2008) Paul Calès et al. JOURNAL OF HEPATOLOGY
- Insulin resistance, inflammation, and non-alcoholic fatty liver disease
- (2008) Herbert Tilg et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More